Medication info
Ultrapen Tablet

Ultrapen Tablet

Prescription medicationTabletOral
Ingredient · strength
Tramadol Hydrochloride›37.5mg / 1 tabletAcetaminophen›325mg / 1 tablet
Manufacturer / importer
Youngpoong Pharmaceutical Co., Ltd.
Appearance
Light yellow rectangular film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200804556 · Notified 2008.04.23 · Insurance code 661902090

Summary

Main use
Relief of moderate~severe acute·chronic pain
Who takes it
Adults · Children
Adult dose
Adults: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, allow an interval of at least 6 hours between doses and do not exceed 8 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this drug for longer than necessary. If long-term use is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this drug should be continued. Elderly patients Use the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when administered orally to patients aged 75 years and older, administer this drug at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended for patients with severe renal impairment (creatinine clearance less than 10ml/min). Since tramadol is removed very slowly by hemodialysis and filtration, there is no need to readminister this drug after dialysis to maintain the analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this drug to patients with severe hepatic impairment.
Child dose
Children aged 12 years and older: An initial dose of 2 tablets is recommended. Thereafter, allow an interval of at least 6 hours between doses and do not exceed 8 tablets per day.

Ingredients

Manufacturer
Youngpoong Pharmaceutical Co., Ltd.

Efficacy & effects

Relief of moderate~severe acute·chronic pain

  • Acute pain
  • chronic pain
View approved original text

This medication is used to relieve moderate to severe acute and chronic pain.

How to take

Adult dose

Adults: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, allow an interval of at least 6 hours between doses and do not exceed 8 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this drug for longer than necessary. If long-term use is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this drug should be continued. Elderly patients Use the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when administered orally to patients aged 75 years and older, administer this drug at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended for patients with severe renal impairment (creatinine clearance less than 10ml/min). Since tramadol is removed very slowly by hemodialysis and filtration, there is no need to readminister this drug after dialysis to maintain the analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this drug to patients with severe hepatic impairment.

Child dose

Children aged 12 years and older: An initial dose of 2 tablets is recommended. Thereafter, allow an interval of at least 6 hours between doses and do not exceed 8 tablets per day.

Precautions

This medication may cause liver damage if taken by individuals who regularly consume more than three alcoholic beverages daily; consultation with a doctor or pharmacist is required. Rarely, serious skin reactions may occur with this medication. If a rash or allergic symptoms develop, discontinue use immediately and consult with medical personnel. One of the active ingredients, tramadol, may increase the risk of seizures, and this risk may be further elevated when taken with certain antidepressants or other narcotic analgesics, so caution is necessary. In rare cases, a life-threatening anaphylaxis reaction may occur with this medication, so if allergic symptoms arise, visit a medical facility immediately. Patients with acute and severe bronchial asthma have a higher risk of respiratory depression when taking this medication; administration should occur in an environment where monitoring is possible. Taking this medication with alcohol or central nervous system depressants can lead to severe drowsiness, respiratory depression, or even coma, therefore co-administration should either be avoided or conducted under medical supervision. Patients with elevated intracranial pressure or those who have a head injury may experience worsening of their condition due to respiratory depression from this medication, so caution is advised. This medication can lead to physical and psychological dependency; therefore, usage should be carefully monitored for dependency if used for an extended period. Patients with impaired liver function are at risk of liver damage when taking this medication, so consult with a doctor before usage. Especially in ultra-rapid metabolizers of CYP2D6, the active metabolite of this medication may increase quickly, raising the risk of respiratory depression, thus necessitating dosage adjustment and monitoring. This medication should not be administered to children under 12 years or adolescents under 18 years who have undergone tonsillectomy or adenoidectomy. Adolescents aged 12 to 18 should also avoid taking it if they have risk factors. This medication may cause sleep apnea and hypoxemia, so continuous observation is necessary for symptoms or exacerbation, and dosage may need to be reduced or discontinued if needed. Elderly patients and those at risk of hyponatremia should be closely monitored for occurrences of hyponatremia while taking this medication. This medication may interact with certain drugs, so inform medical personnel if other medications are being taken, particularly with warnings against co-administration with MAO inhibitors, antidepressants, or central nervous system depressants. Women who are pregnant or may become pregnant should consult a doctor before taking this medication, and nursing mothers should avoid use as it may cause sedation or respiratory depression in infants. This medication may cause drowsiness or dizziness, so caution is needed when driving or operating machinery. In case of overdose, severe respiratory depression, seizures, and liver damage may occur, so adhere to the prescribed dosage and seek immediate emergency treatment in the event of overdose. Store in a secure location out of reach of children to prevent accidental ingestion or misuse.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, hepatotoxicity, hyponatremia, decreased appetite, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, dyspepsia, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, urticaria, hypersensitivity, hypoglycemia, anxiety, nervousness, emotional instability, euphoria, decreased libido, sleep disturbances, confusion, disorientation, agitation, abnormal dreams, drug abuse, hallucinations, withdrawal syndrome, migraines, hypersomnia, sensory loss, tremor, paresthesia, attention deficit, syncope, memory impairment, psychomotor hyperactivity, sedation, amnesia, perceptual disturbances, convulsions, blurred vision, visual impairment, miosis, dizziness, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dry throat, increased liver enzymes, generalized pruritus, diaphoresis, urinary disorders, erectile dysfunction, weakness, chest pain, emotional abnormality, chills, chest discomfort, lethargy, drug withdrawal syndrome, thirst, irritability, heat sensation, weight loss, increased serum creatinine, anaphylaxis reaction, Stevens-Johnson syndrome, toxic epidermal necrolysis, emotional instability, delirium, suicidal ideation, muscle hypertonia, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, hepatitis, gait disturbances, prolonged prothrombin time, thrombocytopenia, agranulocytosis, hematological disorders, thrombocytopenia, anemia, decreased hemoglobin, decreased red blood cells, decreased white blood cells, increased white blood cells, congestive heart failure, vertigo, confusion, exacerbated migraines, involuntary muscle contractions, rectal bleeding, increased cholesterol, tinnitus, chills, hip pain, thigh pain, allergic rhinitis, nasal bleeding, abnormal vision, progression of biliary cancer, foreign body sensation in the eye, progression of liver cancer, liver dysfunction, cholecystitis, paralytic ileus, hiccups, renal function abnormalities, increased salivation, vomiting, dyspepsia, confusion, multiple organ failure, intentional overdose, belching, chest discomfort, withdrawal symptoms, panic attacks, severe anxiety, hallucinations, perceptual disturbances, tinnitus, abnormal central nervous system reactions, urticaria, bronchospasm, toxic skin necrosis, allergic reactions, respiratory arrest, heart attack, QT prolongation, liver failure, renal tubular necrosis, coagulopathy, abdominal discomfort, nausea, lethargy, pallor, hyperhidrosis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air from entering, and it is best stored at room temperature between 1 degree and 30 degrees Celsius. Storing in this manner will help maintain the medication's efficacy for a longer period.

Appearance and packaging

Appearance

Light yellow rectangular film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.